альтернативное лечение и смертность среди онкобольных
 

Пациенты, использующие альтернативное лечение, вместо рекомендованной онкологами терапии рискуют умереть от курабельных форм злокачественных опухолей, подробнее:

Patients who chose complementary medicine (CM) did not have a longer delay to initiation of conventional cancer treatment (CCT) but had higher refusal rates of surgery (7.0% [18 of 258] vs 0.1% [1 of 1031]; P < .001), chemotherapy (34.1% [88 of 258] vs 3.2% [33 of 1032]; P < .001), radiotherapy (53.0% [106 of 200] vs 2.3% [16 of 711]; P < .001), and hormone therapy (33.7% [87 of 258] vs 2.8% [29 of 1032]; P < .001). Use of CM was associated with poorer 5-year overall survival compared with no CM (82.2% [95% CI, 76.0%-87.0%] vs 86.6% [95% CI, 84.0%-88.9%]; P = .001) and was independently associated with greater risk of death (hazard ratio, 2.08; 95% CI, 1.50-2.90) in a multivariate model that did not include treatment delay or refusal.
---
Complementary Medicine, Refusal of Conventional Cancer Therapy, and Survival Among Patients With Curable Cancers
JAMA Oncol. Published online July 19, 2018
[Ссылки могут видеть только зарегистрированные пользователи. ]